Robotic-assisted laparoscopic inguinal hernia repair after previous transabdominal prostatectomy von Dewulf, M., Aspeslagh, L., Nachtergaele, F., Pletinckx, P., Muysoms, F.

Volltext

VE10 Robot-Assisted Laparoscopic extravesical Ureteral Reimplantation (RALUR) in children: Technical illustration of surgical procedure von Gernay, G., Vangeneugden, J., Aspeslagh, L., Jamaer, C., Spinoit, A.-F.

Volltext

Immuno-oncology-101: overview of major concepts and translational perspectives von Allard, B., Aspeslagh, S., Garaud, S., Dupont, F.A., Solinas, C., Kok, M., Routy, B., Sotiriou, C., Stagg, J., Buisseret, L.

Volltext

Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma von Owen, C.N., Bai, X., Quah, T., Lo, S.N., Allayous, C., Callaghan, S., Martínez-Vila, C., Wallace, R., Bhave, P., Reijers, I.L.M., Thompson, N., Vanella, V., Gerard, C.L., Aspeslagh, S., Labianca, A., Khattak, A., Mandala, M., Xu, W., Neyns, B., Michielin, O., Blank, C.U., Welsh, S.J., Haydon, A., Sandhu, S., Mangana, J., McQuade, J.L., Ascierto, P.A., Zimmer, L., Johnson, D.B., Arance, A., Lorigan, P., Lebbé, C., Carlino, M.S., Sullivan, R.J., Long, G.V., Menzies, A.M.

Volltext

1860P Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB) von Vanlaer, N., Dirven, I., Vounckx, M., Tijtgat, J., Verhaert, M., Aspeslagh, S., Decoster, L., Rogiers, A., Neyns, B.

Volltext

Delayed immune-related adverse events with an PD-1-based immunotherapy in melanoma von Owen, C. N., Bai, X., Quah, T., Lo, S. N., Allayous, C., Callaghan, S., Martinez-Vila, C., Wallace, R., Bhave, P., Reijers, I. L. M., Thompson, N., Vanella, V., Gerard, C. L., Aspeslagh, S., Labianca, A., Khattak, A., Mandala, M., Xu, W., Neyns, B., Michielin, O., Blank, C. U., Welsh, S. J., Haydon, A., Sandhu, S., Mangana, J., McQuade, J. L., Ascierto, P. A., Zimmer, L., Johnson, D. B., Arance, A., Lorigan, P., Lebbe, C., Carlino, M. S., Sullivan, R. J., Long, G., Menzies, A. M.

Volltext

Phase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancer von Flament, A., Hendlisz, A., Shaza, L., Aspeslagh, S., Vouche, M., Donckier, V., Awada, A., Machiels, J.-P., van den Eynde, M., Canon, J.-L., Carrasco, J., Lonez, C., Lehmann, F.F.

Volltext

159P Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma von De Jaeghere, E.A., Tuyaerts, S., Van Nuffel, A.M.T., Lippens, L., Hendrix, A., Vuylsteke, P., Henry, S., Trinh, X.B., Van Dam, P.A., Aspeslagh, S., De Caluwe, A., Naert, E., Van de Vijver, K., Amant, F., Vandecasteele, K., Denys, H.G.

Volltext

First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1) von Postel-Vinay, Sophie, Lam, Vincent K, Ros, Willeke, Bauer, Todd M, Hansen, Aaron R, Cho, Daniel C, Stephen Hodi, F, Schellens, Jan H M, Litton, Jennifer K, Aspeslagh, Sandrine, Autio, Karen A, Opdam, Frans L, McKean, Meredith, Somaiah, Neeta, Champiat, Stephane, Altan, Mehmet, Spreafico, Anna, Rahma, Osama, Paul, Elaine M, Ahlers, Christoph M, Zhou, Helen, Struemper, Herbert, Gorman, Shelby A, Watmuff, Maura, Yablonski, Kaitlin M, Yanamandra, Niranjan, Chisamore, Michael J, Schmidt, Emmett V, Hoos, Axel, Marabelle, Aurelien, Weber, Jeffrey S, Heymach, John V

Volltext

Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells von Braet, Katleen, Aspeslagh, Sandrine, Vandamme, Wouter, Willecke, Klaus, Martin, Patricia E. M., Evans, W. Howard, Leybaert, Luc

Volltext

114P Real-world insights on pan-cancer immune checkpoint inhibitor treatment: Initial findings of a Belgian multicenter study von Verbiest, A.T.L., Delombaerde, D.L., Verhaert, M., Tack, L., Oeste, C.L., Cool, L., Croes, L., Bassez, I., Hens, D.F.E., Franssen, C., Aspeslagh, S., Geldhof, V., Debruyne, P.R., Vulsteke, C.

Volltext

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future von Geukens, T., Brandão, M., Laenen, A., Collignon, J., Van Marcke, C., Louviaux, I., Demey, W., Van Wambeke, S., Schrijvers, D., Lecomte, S., Mebis, J., Rutten, A., Fontaine, C., Lybaert, W., Aspeslagh, S., Goeminne, J.-C., Van Den Bulck, H., Seront, E., De Backer, L., De Roock, W., Ignatiadis, M., Prenen, H., Van Beckhoven, D., Heijlen, M., Verheezen, J., Rottey, S., Punie, K., de Azambuja, E.

Volltext

2880 Immunohistochemical analysis of CD70 expression in 95 cases of squamous cell carcinoma of the head and neck: Correlation with clinicopathological variables and identification... von De Meulenaere, A, Vermassen, T, Aspeslagh, S, Deron, P, Duprez, F, Silence, K, Jacobs, J, Zwaenepoel, K, Pauwels, P, Rottey, S, Ferdinande, L

Volltext

612TiPPhase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancer von Flament, A, Hendlisz, A, Shaza, L, Aspeslagh, S, Vouche, M, Donckier, V, Awada, A, Machiels, J-P, van den Eynde, M, Canon, J-L, Carrasco, J, Lonez, C, Lehmann, F F

Volltext

Abstract CT150: A first-in-human phase I study of the OX40 agonist GSK3174998 (GSK998) +/- pembrolizumab in patients (Pts) with selected advanced solid tumors (ENGAGE-1) von Postel-Vinay, Sophie, Lam, Vincent K., Ros, Willeke, Bauer, Todd M., Hansen, Aaron R., Cho, Daniel C., Hodi, F. Stephen, Schellens, Jan H.M., Litton, Jennifer K., Aspeslagh, Sandrine, Autio, Karen A., Opdam, Frans L., McKean, Meredith, Somaiah, Neeta, Champiat, Stephane, Altan, Mehmet, Spreafico, Anna, Rahma, Osama, Paul, Elaine M., Ahlers, Christoph M., Zhou, Helen, Struemper, Herbert, Gorman, Shelby A., Watmuff, Maura, Yablonski, Kaitlin M., Yanamandra, Niranjan, Chisamore, Michael J., Schmidt, Emmett V., Hoos, Axel, Marabelle, Aurélien, Weber, Jeffrey S., Heymach, John V.

Volltext

A novel radiomic based imaging tool to monitor tumor lymphocyte infiltration and outcome of patients treated by anti-PD-1/PD-L1 von Sun, R., Limkin, E.J., Dercle, L., Champiat, S., Reuzé, S., Brandao, D., Verlingue, L., Ammari, S., Aspeslagh, S., Schernberg, A., Postel-Vinay, S., Hollebecque, A., Massard, C., Marabelle, A., Robert, C., Soria, J.-C., Deutsch, E., Ferté, C.

Volltext

Long term survival in patients responding to an Anti-PD-1/PD-L1 therapy and disease outcome upon treatment discontinuation von Gauci, M-L., Lanoy, E., Champiat, S., Michot, J-M., Varga, A., Bahleda, R., Angevin, E., Gazzah, A., Verlingue, L., Bigot, F., Aspeslagh, S., Castanon, E., Baldini, C., Postel-Vinay, S., Massard, C., Hollebecque, A., Soria, J-C., Marabelle, A.

Volltext

Is anti-PD-1/PD-L1 immunotherapy sensitizing for conventional cancer therapies? von Matias, M., Aspeslagh, S., Palomar, V., Lanoy, E., Dercle, L., Even, C., Ferte, C., Hollebecque, A., Marabelle, A., Massard, C., Soria, J.-C., Postel-Vinay, S.

Volltext

Clinical efficacy of HER3 partners' inhibitors in ERBB3 mutated cancer patients von Verlingue, L., Massard, C., Hollebecque, A., Alvarez, E. Castanon, Postel-Vinay, S., Angevin, E., Armand, J.-P., Aspeslagh, S., Varga, A., Ratislav, B., Gazzah, A., Michot, J.-M., Lacroix, L., De Baere, T., Marabelle, A., Soria, J.-C.

Volltext

Rapid and objective CT-scan prognostic scoring identifies patients with long-term clinical benefit on phase I trials von Dercle, L., Ammari, S., Champiat, S., Massard, C., Ferte, C., Texier, M., Lanoy, E., Taihi, L., Seban, R.-D., Aspeslagh, S., Antoun, S., Mahjoubi, L., Kamsu-Kom, N., Robert, C., Marabelle, A., Schlumberger, M., Soria, J.-C., Postel-Vinay, S.

Volltext